Remove Finance Remove Health Care Remove Operations Remove Venture Capitalist
article thumbnail

How Merck Is Trying to Keep Disrupters at Bay

Harvard Business Review

With its Emerging Businesses (EB) group (where one of us serves as President), Merck started a journey about three years ago with a core investment thesis: there are areas of growing unmet need in health care that intersect with its established competencies.

article thumbnail

Big Companies Can Unleash Innovation, Rather than Shackle It

Harvard Business Review

Here's why: the innovation revolution spurred by venture capitalists decades ago has created the conditions in which scale allows big companies to shift from shackling innovation to unleashing it. It worked with a local partner to create India's first financing plan for medical devices.